Blood sugar markers to spot gestational diabetes after weight-loss surgery
Studies whether routine blood and urine sugar checks can predict gestational diabetes after bariatric surgery.
Key facts
- Who runs it
- Burak Deniz Aydoğdu
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Glycemic Markers for Predicting Gestational Diabetes in Pregnant Women With Previous Bariatric Surgery
- Status
- Recruiting
- People taking part
- 84 people, planned
- Started
- 1 Feb 2026
- Expected to end
- Dec 2027
- Type of study
- Observational, 2 groups
- Record updated
- 8 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women who had weight-loss (bariatric) surgery before pregnancy. It checks whether routine blood sugar tests can predict diabetes in pregnancy.
- Age
- 18 to 50 years
- Sex
- Women only
- Disease stage
- Pregnant with one baby. Followed at Prof. Dr. Cemil Taşcıoğlu City Hospital, Department of Obstetrics and Gynecology.
- Earlier treatment
- Must have had bariatric surgery before the pregnancy.
- Biomarker or test result
- Blood sugar results must be available from early pregnancy (≤14 weeks) and/or 24 to 28 weeks: fasting plasma glucose, HbA1c, urine glucose, and/or OGTT if tolerated.
Main reasons for not taking part
- Pregnant with more than one baby
- Known long-term body-wide disease, such as diabetes before pregnancy or hormone disorders
- Incomplete or missing clinical data, including ultrasound and follow-up from 28 weeks to delivery
This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant women aged 18-50 years
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Pregnant women aged 18-50 years
- Singleton pregnancy
- History of bariatric surgery prior to pregnancy
- Followed at Prof. Dr. Cemil Taşcıoğlu City Hospital, Department of Obstetrics and Gynecology
- Availability of glycemic parameters during early pregnancy (≤14 weeks) and/or between 24 and 28 weeks of gestation (fasting plasma glucose, HbA1c, urine glucose, and/or OGTT results if tolerated)
- Availability of sonographic and clinical follow-up data between 28 weeks of gestation and delivery (up to 40 weeks) Exclusion Criteria
- Age <18 years or >50 years
- Multiple pregnancy
- Presence of known chronic systemic disease (e.g., pregestational diabetes or endocrine disorders)
- Incomplete or missing clinical data
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
This trial is currently available in Türkiye.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Gestational diabetes mellitus (GDM) is associated with significant maternal and fetal complications. The standard diagnostic test for GDM is the 75-gram oral glucose tolerance test (OGTT). However, pregnant women who have undergone bariatric surgery may not tolerate OGTT due to dumping syndrome and gastrointestinal side effects. This creates diagnostic challenges in this specific population.
Read full original descriptionShow less
The aim of this prospective observational study is to evaluate whether routinely measured glycemic markers, including fasting blood glucose, postprandial blood glucose, HbA1c, and urinary glucose levels, can predict the development of gestational diabetes mellitus and related pregnancy complications in women with prior bariatric surgery.
Pregnant women aged 18-50 years with a history of bariatric surgery will be enrolled and followed throughout pregnancy. The predictive value of glycemic markers for GDM, macrosomia, and polyhydramnios will be analyzed using multivariable logistic regression models.
This study aims to provide alternative diagnostic approaches for GDM screening in pregnant women who are unable to tolerate OGTT and to contribute to improving maternal and perinatal outcomes in this growing patient population.
The 2 groups in the trial
- OGTT Tolerant Group
Pregnant women with a history of bariatric surgery who tolerate and complete the 75-gram oral glucose tolerance test during pregnancy.
- OGTT Non-Tolerant Group
Pregnant women with a history of bariatric surgery who are unable to tolerate or refuse the 75-gram oral glucose tolerance test during pregnancy.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Predictive Value of Glycemic Markers for Gestational Diabetes Mellitus and Pregnancy Complications in Pregnant Women With Prior Bariatric Surgery Who Cannot Tolerate Oral Glucose Tolerance Testing
- Plain-language title
- Blood sugar markers to spot gestational diabetes after weight-loss surgeryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT07517406, who can take part
- Record updated
- 8 April 2026